Sitravatinib in Metastatic Breast Cancer

Clinical trial NCT04123704 · TERMINATED

Trial details

NCT number: NCT04123704
Sponsor: Xiang Zhang
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Stage IV Triple Negative Breast Cancer Breast Neoplasms Breast Cancer Metastatic

Start date: 2021-09-22
Primary completion: 2023-01-22
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.